Subscribe to RSS
Download PDF
DOI: 10.4103/ijmpo.ijmpo_16_19
B-Acute Lymphoblastic Leukemia in a Follow-up Case of Breast Cancer
Financial support and sponsorship Nil.
Sir,
Therapy-related leukemias are a well-known complication of the treatment of solid or hematological malignancies. Among solid malignancies, breast cancer is the most common cause of therapy-related leukemias. Therapy-related leukemias usually present within 5–7 years of the primary treatment. The majority of these leukemias are of the myeloid lineage, but therapy-related acute lymphoblastic leukemia (t-ALL) has been rarely described. Because of the rarity, the clinical and molecular markers have been poorly described in t-ALL. Hence, we report a case of B-acute lymphoblastic leukemia (ALL) developing in a patient of carcinoma breast on follow-up.
Publication History
Received: 23 January 2019
Accepted: 06 October 2019
Article published online:
23 May 2021
© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Aldoss I, Stiller T, Tsai NC, Song JY, Cao T, Bandara NA. et al. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients. Haematologica 2018; 103: 1662-8
- 2 Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan TH. et al. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J 2017; 7: e605
- 3 Abdulwahab A, Sykes J, Kamel-Reid S, Chang H, Brandwein JM. Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis. Cancer 2012; 118: 3962-7
- 4 Shivakumar R, Tan W, Wilding GE, Wang ES, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia – A review of 101 cases. Ann Oncol 2008; 19: 1634-8
- 5 Pagano L, Pulsoni A, Mele L, Leone G. Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy. Leuk Lymphoma 2000; 39: 465-75
- 6 Ishizawa S, Slovak ML, Popplewell L, Bedell V, Wrede JE, Carter NH. et al. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia 2003; 17: 1091-5
- 7 Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE. et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 1992; 304: 951-8
- 8 Tang G, Zuo Z, Thomas DA, Lin P, Liu D, Hu Y. et al. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: Is it therapy-related?. Haematologica 2012; 97: 919-25
- 9 Bhatia P, Das R, Ahluwalia J, Malhotra P, Varma N, Varma S. et al. Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: A report of five cases from North India. Indian J Pathol Microbiol 2009; 52: 167-70